Articles

J&J wins OK for first in new class of diabetes drugs

Johnson & Johnson, the world’s largest seller of health-care products, won approval for the first in a new family of diabetes drugs, giving them the edge against rivals including Eli Lilly and Co. that are developing similar medicines.

Read More

Rolls-Royce late with key part for F-35 fighter

Rolls-Royce Holdings Plc was an average of 160 days late last year in delivering equipment needed for the U.S. Marine Corps version of the F-35 fighter to hover and land like a helicopter, according to the Pentagon.

Read More

NCAA titles don’t guarantee windfalls for universities

While supporters of big-time college athletics say basketball championships increase sports revenue, stimulate fundraising and encourage student applications, data compiled by Bloomberg News show that not all of that is true, and there’s no guarantee of a lasting effect.

Read More